Context Therapeutics Stock (NASDAQ: CNTX) stock price, news, charts, stock research, profile.
Open | $1.840 |
Close | $2.000 |
Volume / Avg. | 617.683K / 547.977K |
Day Range | 1.780 - 2.100 |
52 Wk Range | 0.485 - 2.010 |
Market Cap | $150.747M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 0.01% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Context Therapeutics (NASDAQ: CNTX) through any online brokerage.
Other companies in Context Therapeutics’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Context Therapeutics (NASDAQ: CNTX) was reported by Piper Sandler on Thursday, May 16, 2024. The analyst firm set a price target for 4.50 expecting CNTX to rise to within 12 months (a possible 123.88% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Context Therapeutics (NASDAQ: CNTX) is $2.01 last updated May 17, 2024 at 7:51 PM EDT.
There are no upcoming dividends for Context Therapeutics.
Context Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Context Therapeutics.
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.